Home > Insider Trading > Filing (0001237899-13-000043)

Filing Details

Accession Number:: 0001237899-13-000043
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-12 09:15:25
Reporting Period:: 2013-06-10

Filing Date:: 2013-06-12
Accepted Time:: 2013-06-12 09:15:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1225470	A Charles Baker	777 Old Saw Mill River Road Tarrytown NY 10591		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-06-10	15,000	$15.80	24,000	No	4	M	Direct
Common Stock	Disposition	2013-06-10	4,150	$250.06	19,850	No	4	S	Direct
Common Stock	Disposition	2013-06-10	3,938	$251.67	15,912	No	4	S	Direct
Common Stock	Disposition	2013-06-10	4,748	$252.32	11,164	No	4	S	Direct
Common Stock	Disposition	2013-06-10	908	$253.50	10,256	No	4	S	Direct
Common Stock	Disposition	2013-06-10	756	$254.10	9,500	No	4	S	Direct
Common Stock	Disposition	2013-06-10	200	$255.16	9,300	No	4	S	Direct
Common Stock	Disposition	2013-06-10	300	$257.99	9,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-06-10	15,000	$0.00	15,000	$15.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2016-01-03	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	590	Indirect	by Partnership

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 4,150 shares of Company stock on June 10, 2013 at prices ranging from $250.00 to $250.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
Represents volume-weighted average price of sales of 3,938 shares of Company stock on June 10, 2013 at prices ranging from $251.15 to $251.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
Represents volume-weighted average price of sales of 4,748 shares of Company stock on June 10, 2013 at prices ranging from $252.00 to $252.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
Represents volume-weighted average price of sales of 908 shares of Company stock on June 10, 2013 at prices ranging from $253.11 to $253.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
Represents volume-weighted average price of sales of 756 shares of Company stock on June 10, 2013 at prices ranging from $254.04 to $254.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
Represents volume-weighted average price of sales of 300 shares of Company stock on June 10, 2013 at prices ranging from $257.98 to $257.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.